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Cytochrome P450 monooxygenases (CYPs/P450s) are found in all domains of life and are 
known for their catalytic versatility and stereo- and regio-specific activity. While the impact of 
lifestyle on P450 evolution has been reported in many eukaryotes, this remains to be addressed 
in bacteria. In this report, Streptomyces and Mycobacterium, belonging to the phylum 
Actinobacteria, were studied owing to their contrasting lifestyles and impact on human beings.  
Genome-wide data mining and annotation of P450s in 48 Streptomyces species 
revealed the presence of 1 625 P450s in their genomes. Of these 1 625 P450s, all had 
characteristic glutamic acid and cysteine at the EXXR and CXG motifs, respectively; however, 
34 P450s lacked one or both P450 characteristic motifs, EXXR and CXG, owing to their short 
amino acid sequences and were thus regarded as fragment/pseudo-P450s. Comparison of P450s 
revealed that species belonging to the genera Streptomyces and Mycobacterium had almost the 
same patterns in terms of the average number of P450s in their genomes. All 1 625 P450 
identified in 48 Streptomyces species were grouped into 144 P450 families and 377 P450 
subfamilies. Among the families and subfamilies, 66 new P450 families and 144 new P450 
subfamilies were identified in Streptomyces species. Analysis of P450 family conservation 
across 48 Streptomyces species revealed that among 144 P450 families identified, only two 
P450 families, the CYP107 and CYP157 P450 families, are conserved across 
all Streptomyces species.  
Comparative analysis of P450 family dynamics between the 
genera Streptomyces and Mycobacterium revealed the presence of the highest number of P450 
families and P450 subfamilies in Streptomyces species. Streptomyces species have 144 P450 
families and 377 P450 subfamilies, compared to 77 P450 families and 132 P450 subfamilies in 
mycobacterial species. Streptomyces species also have the highest number of new P450 
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families (66 families) and new P450 subfamilies (144 subfamilies) in their genomes compared 
to mycobacterial species. Interestingly, only two P450 families (CYP107 and CYP157) were 
conserved in Streptomyces compared to mycobacterial species where 10 P450 families, namely 
CYP51, CYP123, CYP125, CYP130, CYP135, CYP136, CYP138, CYP140, CYP144 and 
CYP1128, were conserved. Furthermore, P450 diversity percentage analysis between two 
genera revealed that Streptomyces species had almost double the P450 diversity percentage 
(0.18%) than mycobacterial species (0.07%). Comparative analysis of P450 profiles between 
the genera Streptomyces and Mycobacterium revealed that species belonging to these genera 
have different P450 profiles with few similarities. Despite both genera belonging to the same 
phylum, Actinobacteria, only 21 P450 families were found to be common and quite a large 
number of P450 families were found to be unique to Streptomyces (123 P450 families) 
and Mycobacterium (56 P450 families). In the 21 P450 families commonly found between the 
two genera, an interesting feature was observed in terms of the number of member P450s.  
A significant difference in the number of member P450s in the commonly shared P450 
families was observed between Streptomyces and Mycobacterium. Differences were also 
observed in the number of dominant P450 families in the two genera. Only seven P450 families, 
namely CYP107, CYP105, CYP157, CYP154, CYP156, CYP147 and CYP183, contributed 
62% of all P450s in Streptomyces species, whereas 15 P450 families, namely CYP125, 
CYP189, CYP150, CYP136, CYP135, CYP138, CYP140, CYP123, CYP143, CYP142, 
CYP144, CYP124, CYP108, CYP51 and CYP187, contributed 60% of all P450s 
in Mycobacterium. Furthermore, differences in P450 profiles between the two genera were 
observed in terms of type of dominant P450 families. A comparison of the dominant P450 
families between the two genera revealed that none of the dominant P450 families was common 
between them. This strongly supports the concept that these Streptomyces P450s play a key 
role in the production of chemically diverse secondary metabolites, as a large number of P450 
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families were found in 48 Streptomyces species. P450 families, namely CYP105, CYP107, 
CYP161, and CYP183, which are highly populated in Streptomyces species compared to 
mycobacterial species, were found to be involved in secondary metabolite production. In 
contrast to the P450 families highly populated in Streptomyces species, P450 families that are 
highly populated in mycobacterial species, such as CYP125, CYP124, CYP108, CYP140 and 
CYP268, are involved in steroid (cholesterol) and hydrocarbon (lipids, alkenes, long chain 
acetate and ketone) hydroxylation, suggesting that these P450 families possibly help 
mycobacterial species to assimilate the host compounds. 
It is clear that different lifestyles influenced the P450 profiles in Streptomyces and 
Mycobacterium, hence the differences observed between the two genera in terms of number of 
P450s, P450 family and subfamily diversity, dominant and unique P450 families types and 
differences in number of P450s in common P450 families. Furthermore, functional analysis of 
P450s suggests that in Streptomyces, P450s are destined for secondary metabolite production, 
whereas in Mycobacterium they are destined for utilisation of host lipids or synthesis of novel 
lipids. Based on the evidence presented in this study, the researcher hereby proposes that 
lifestyle or ecological niches play a key role in the evolution of P450 profiles in species 
belonging to the genera Streptomyces and Mycobacterium. 
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Streptomyces is the largest genus in the phylum Actinobacteria (Ventura et al., 2007). 
Streptomyces species are spore-forming filamentous bacteria and commonly known to produce 
various secondary metabolites including antibiotics (de Lima Procópio et al., 2012). It is 
estimated that more than 50% of commercially available antibiotics are produced by 
Streptomyces species (de Lima Procópio et al., 2012). A survey of the characteristics of 
Streptomyces species revealed that most of the species belonging to this genus produce 
chemically diverse secondary metabolites that are used in human medicine as antibiotics, anti-
infective, anti-fibrotic, anti-tumour and immunosuppressant drugs. Much of the chemical 
diversity of secondary metabolites produced by Streptomyces species has been attributed to 
their symbiotic lifestyle, apart from their well-known saprophytic lifestyles (Seipke et al., 
2012). Symbiosis of Streptomyces species with plants, fungi, and animals has been reported 
and in some cases parasitic symbiosis was identified (Seipke et al., 2012). Streptomyces species 
are known to produce geosmin, a volatile metabolite that is responsible for their characteristic 
“earthy” smell, and P450s were found to be involved in the production of this metabolite (Lamb 
et al., 2003). On the other hand, the genus Mycobacterium includes pathogens known to cause 
serious diseases (Ventura et al., 2007) Generally, mycobacterial species are rod-shaped and 
some species show pleomorphism (Scherr and Nguyen, 2009). The Mycobacterium genus is 
well known for its human and animal pathogens, especially M. tuberculosis, a deadly human 
pathogen that is responsible for the death of millions of people across the world (Quan et al., 
2017). In a recent study mycobacterial species were classified into six different categories 
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based on their lifestyles, site of infection, and other characteristics (Parvez et al., 2016). While 
most of the mycobacterial species are pathogens, some are saprophytes with potential 
biotechnological applications, such as bioremediation. Comprehensive comparative analysis of 
P450s in the genus Mycobacterium revealed that progression from soil mycobacteria into 
human pathogens, such as those living in human blood and ultimately adapted as a lung 
pathogen, resulted in gradual loss of a considerable number of P450s (Parvez et al., 2016). 
Furthermore, species belonging to each of the six categories were found to have category-
specific P450s that can be used as a diagnostic marker in the detection and distinction of these 
species (Parvez et al., 2016). 
1.2 Problem statement and rationale for the study 
Cytochrome P450 monooxygenases (P450s/CYPs) are ubiquitously distributed in all domains 
of life, and even found in some non-living entities such as viruses (Lamb et al., 2009, Nelson, 
2018). P450s are catalytically versatile and perform stereo- and regio-specific enzymatic 
reactions (Bernhardt, 2006, Sono et al., 1996). 
Because of this unique nature, P450s have been in focus for more than five decades 
(Yamazaki, 2014). Whole genome sequencing of various organisms belonging to different 
biological domains and kingdoms have resulted in identification of more than 300 000 P450s 
(Nelson, 2018). Analyses of P450 evolutionary patterns with respect to species and their 
ecological niches is gaining great momentum. This type of study has been reported involving 
eukaryotes, animals (Feyereisen, 2011), plants (Du et al., 2016, Hamberger and Bak, 2013, Ma 
et al., 2014), fungi (Jawallapersand et al., 2014, Kgosiemang et al., 2014, Matowane et al., 
2018, Ngwenya et al., 2018, Parvez et al., 2016, Qhanya et al., 2015, Suzuki et al., 2012, Syed 
et al., 2014) and oomycetes (Sello et al., 2015). In the reported studies researchers observed 
blooming of certain P450 families, the presence of unique P450 families or changes in the 
© Central University of Technology, Free State
4 
number of P450s with respect to species adaptation to specific ecological niches or lifestyles. 
However, to date, this type of evolutionary analysis has not been reported for bacteria. To 
address this research gap, the researcher selected two genera, Streptomyces and 
Mycobacterium, belonging to the phylum Actinobacteria (Ventura et al., 2007), and assessed 
the impact of lifestyle on the evolution of P450s. 
1.3 Aims and objectives of the study 
1.3.1 Aims of the study 
 Genome data mining, identification, annotation and phylogenetic analysis of P450s in
48 Streptomyces species.
 Comparative analysis of P450s between the genera Streptomyces and Mycobacterium.
1.3.2 Objectives of the study 
 Genome data-mining and identification of P450s in 48 Streptomyces species.
 Annotation of P450s in 48 Streptomyces species.
 Phylogenetic analysis of P450s in 48 Streptomyces species.
 P450 diversity analysis.
 Functional prediction of Streptomyces P450s.
 Comparative analysis of P450s between the genera Streptomyces and Mycobacterium.
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Among living organisms are many species of different nature, which are classified into groups 
based on very basic, shared characteristics. The two basic types of cells, eukaryotes and 
prokaryotes, are used to classify living organisms (Black, 2008) and are further organised into 
three domains: Archea, Eubacteria and Eukaryote (Pang et al., 2004, Woese, 2000, Woese et 
al., 1990). Organisms in each group are divided into smaller groups. One of the commonly 
studied groups is the bacterial kingdom. The bacterial kingdom, being prokaryotes, is further 
divided into different phyla, including the Actinobacteria, which contain diverse groups of 
bacteria, such as the medically important bacteria belonging to the genus Streptomyces (Sun et 
al., 2018, Ventura et al., 2007), which will be the focus of this study.  
Streptomyces is the largest genus in the phylum Actinobacteria (Panpatte et al., 2018, 
Qin et al., 2016, Ventura et al., 2007). Members of the genus Streptomyces are the most 
complex: they grow as a mycelium with branching hyphal filaments (between 0.5-2.0 µm in 
diameter), and reproduce in a mould-like manner by sending up aerial branches that turn into 
chains of spores. Although the aerial hyphae that arise from them are motile, mobility is 
achieved by dispersion of spores. Spore surfaces may be hairy, rugose, smooth or warty. They 
demonstrate a complex morphology; their life cycle involves formation of aerial mycelium or 
filaments from a substrate mycelium when their spores germinate. This process occurs during 
morphological differentiation (Chater, 1998, Claessen et al., 2006, Dyson, 2011, Flärdh and 
Buttner, 2009). These filamentous Gram-positive actinomycete bacteria live in soil and water 
as decomposers of organic material. In soil, they behave much like fungi, helping to decompose 
© Central University of Technology, Free State
10 
 
the organic matter of dead organisms so the molecules can be taken up anew by plants. Found 
predominantly in soil and decaying vegetation, most Streptomycetes produce spores (Chater 
and Merrick, 1979:107), and are noted for their distinct "earthy" odour that results from the 
production of a volatile compound, geosmin (Gerber and Lechevalier, 1965, Jiang et al., 2007, 
Maheshwari, 2014).  
Streptomycetes play an important role in carbon recycling. They act as versatile 
decomposers through their expression and secretion of a large number of hydrolases, such as 
chitinase and cellulase, and many other enzymes, to the extracellular environment. These 
enzymes degrade organic matter to simpler forms, especially biopolymers such as 
lignocellulose and chitin, from the insoluble remains of other organisms (Chater, 1984, Gilbert 
et al., 1995, Schirawski and Perlin, 2018, Vetrivel et al., 2001, Zhou et al., 2016b). Their 
genome consists of a huge number of hydrolases, which constitute 211 gene families that act 
on a wide range of substrates. The cluster consists of 38 families that hydrolyse peptide bonds, 
22 families that act on carbon-nitrogen (but not peptide) bonds, 19 families that hydrolyse 
O- glycosyl compounds, 12 families that act on ester bonds, 10 families that act on acid 
anhydrides, and seven families that hydrolyse N-glycosyl compounds (Zhou et al., 2016a). 
Initially, over 500 species of Streptomyces were described (Euzeby, 2008). Later, close to 576 
Streptomyces species were mentioned (Labeda, 2011). With the number increasing every year, 
Parte (2014) then described 778 species of Streptomyces. Since then new additions have been 
made and to date 848 species of Streptomyces have been described in the list of prokaryotic 
names with standing in nomenclature (Parte, 2018). 
Some Actinomycetes form symbioses with plants, while a few are pathogenic to plants, 
humans and animals (Kers et al., 2005, VanMeter and Hubert, 2015, Zhang and Loria, 2017). 
Examples of plant-pathogenic Streptomyces spp. include S. scabies, S. acidiscabies, 
S.  turgidiscabies, and S. ipomoeae, which have been found to share virulence factors, including 
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thaxtomins (Huguet-Tapia and Loria, 2012). In humans a few, such as S. somaliensis and 
S. sudanensis (Quintana et al., 2008) causing mycetoma, have been described.  
As with the other Actinobacteria, Streptomycetes have genomes with high G+C content 
and are also known to have a linear chromosome (Madigan and Martinko, 2006, Meurant, 
2012). Streptomyces microorganisms are known to carry interesting gene clusters of secondary 
metabolites (Gomez-Escribano and Bibb, 2011, Gomez-Escribano et al., 2015, Ikeda et al., 
2003, Medema et al., 2011, Ōmura et al., 2001). Many of these secondary metabolites have 
been isolated and developed as highly successful drugs in the treatment of human 
diseases (Al- Dhabi et al., 2018, Chater, 2006, de Lima Procópio et al., 2012, Demain, 1999, 
Olano et al., 2009, Ōmura et al., 2001). Streptomyces species use these metabolites to compete 
with fungi and other bacteria for resources in the environment (Hibbing et al., 2010, Kinkel et 
al., 2014, Slattery et al., 2001, Van der Meij et al., 2017). Streptomyces species products are 
also widely used in agriculture as herbicides and pesticides, and in veterinary practice (Dayan 
et al., 2009, Dayan et al., 2012, Duke and Dayan, 2011, Korres et al., 2018, Ōmura et al., 2001, 
Senseman, 2007). They are also used in the production of volatile substances (Gust et al., 2003, 
Li et al., 2012) and liquefaction of coal (Ghani et al., 2015, Gupta et al., 1988, Sekhohola et 
al., 2013, Torzilli and Isbister, 1994).  
 
A review revealed that genes for the synthesis of such secondary metabolites probably 
developed millions of years ago (Baltz, 2006). The common ancestor of modern 
Streptomycetes is said to have lived about 440 million years ago, when it was probably 
involved in the colonisation of the land by green plants (Chater and Chandra, 2006). However, 
it was only in the 1940s that their antibiotic properties were discovered (Waksman and 
Woodruff, 1941). The first true antibiotic identified was from S. antibiotics (formerly known 
as Actinomyces antibioticus) and its product was termed actinomycin. Actinomycin could 
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display both bacteriostatic and bactericidal properties. Waksman and co-workers discovered 
new natural inhibitory substances, including streptomycin and neomycin (Kingston, 2004). 
They proposed the standard term “antibiotics” for this class of natural growth inhibitors 
produced by Actinomycetes, including Streptomycetes (Kingston, 2004). Antibiotics are 
defined as low-molecular-weight organic natural products (secondary metabolites) made by 
microorganisms that are active against other microorganisms at low concentration. Since 1940, 
the majority of antibiotics discovered have been those produced by the Streptomycetes (Gómez 
et al., 2012, Norouzi et al., 2018), making Streptomyces the largest antibiotic-producing genus 
of Actinobacteria (Figure 2.1) (de Lima Procópio et al., 2012).  
 
Figure 2. 1. List of antibiotics produced by Streptomycetes (taken from de Lima Procópio et al, 
2012).  
 
Streptomycetes are also an important source of clinically important 
immunosupressants, including sirolimus (also known as rapamycin) and tacrolimus that are 
used extensively in transplant operations (Kunz and Hall, 1993). Because of the commercial 
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importance of the secondary metabolites produced by Streptomycetes, there has been 
considerable investment in the development of methods for molecular genetic manipulation of 
Streptomycetes (Berdy, 1995, Demain, 1999). 
 
Many decades after the first successful use of antibiotics in the treatment of infections, 
bacterial infections now pose a serious concern (Spellberg and Gilbert, 2014). The current 
antibiotic resistance has rendered a large number of these compounds ineffective (McArthur et 
al., 2013). Antibiotics that were discovered are no longer considered effective for treatment 
owing to resistance. Figure 2.2 illustrates the year of discovery of antibiotics and their current 
status with regard to resistance. The antibiotic resistance crisis is mostly attributed to the 
overuse (Read and Woods, 2014) and misuse (Luyt et al., 2014) of these medications, as well 
as lack of new drug development by the pharmaceutical industry (Bartlett et al., 2013). These 
mediations have been used so widely and for so long that infectious organisms have adapted to 
the antibiotics that are intended for their destruction (Read and Woods, 2014, Ventola, 2015), 
making the drugs less effective. According to the Centre for Disease Control (CDC, 2017), 
each year in the United States, at least 2 million people become infected with bacteria that are 
resistant to antibiotics, resulting in the death of at least 23 000 people.  
 




Figure 2. 2. Timelines of antibiotic discovery and development of drug resistance by bacterial 
species (taken from Spellberg and Gilbert, 2014).  
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In addition, a number of the antibiotics produced by Streptomycetes have demonstrated 
toxicity when used in humans. For example actinomycin is toxic to dividing cells, therefore it 
has been deployed as an anti-cancer drug (Philips et al., 1960). Doxorubicin, made by 
S.  peucetius, is used as a treatment for several types of cancers (Arcamone et al., 1969), even 
though it has been reported for cardio-toxicity (Thorn et al., 2011). 
Even though the antibacterial market has entered a critical phase, one that poses 
numerous challenges, at the same time it also offers opportunities (Gould and Bal, 2013). When 
the Streptomyces coelicolor genome was decoded in 2001 (Bentley et al., 2002a), it revealed 
that there were many previously unknown potentially bioactive substances that have the 
potential to produce new antibiotics. Since then work on different Streptomyces species 
genome sequencing has been published to identify gene clusters that produce antibiotics 
(Table 2.1) (Harrison and Studholme, 2014). It is organisms such as Streptomyces species that 
give room and potential for the development of innovative new medicines and other products 
(de Lima Procópio et al., 2012). Recently, three Streptomyces species with antibacterial activity 
against multi-drug-resistant bacteria, especially methicillin-resistant Staphylococcus aureus 
and vancomycin-resistant Enterococcus, were identified (Norouzi et al., 2018). In one study, 
three species of Streptomyces demonstrated strong inhibitory activity against quite a number 
of other bacterial species (Risdian et al., 2018). In one study, Streptomyces species was found 
to inhibit the growth of disease causing pathogens such as carbapenem-resistant Acinetobacter 
baumannii, vancomycin-resistant Enterococcus faecium, and methicillin-resistant 
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Table 2. 1. Information on some Streptomyces species and their well-known functions 
(taken from Harrison and Studholme, 2014).   





Dodd et al., 2013 
Streptomyces albus  
J1074 
Widely used host for heterologous 
expression of bioactive natural 
products.  
Zaburannyi et al., 2014  
Streptomyces albulus PD‐1  Produces ε‐poly-L‐lysine and 
poly‐L‐diaminopropionic acid 
antibiotics. 
Xu et al., 2014 
Streptomyces bottropensis  
ATCC 25435  
Produces bottromycin antibiotics. Zhang et al., 2013 
Streptomyces collinus  
Tu 365  
Producer the elfamycin-family 
antibiotic kirromycin. 
Rückert et al., 2013 
Streptomyces exfoliatus  
DSMZ 41693  
Degrades poly (3‐
hydroxyalkanoate). 
Martínez et al., 2014 
Streptomyces fulvissimus  
DSM 40593  




Streptomyces mobaraensis  
DSM 40847  
Industrial producer of 
transglutaminase. 
Yang et al., 2013 
Streptomyces niveus  
NCIMB 11891  
Produces novobiocin, an 
aminocoumarin antibiotic. 
Flinspach et al., 2014 
Streptomyces rapamycinicus
NRRL 5491  
Produces the immunosuppressant 
drug rapamycin. 
Baranasic et al., 2013 
Streptomyces rimosus ATCC 
10970  
Oxytetracycline Pethick et al., 2013 
Streptomyces  
roseochromogenes  
subsp. oscitan DS 12.976  
Produces clorobiocin, an 
aminocoumarin antibiotic. 
Rückert et al., 2014 
Streptomyces sp. Mg1 Causes lysis and degradation 
of Bacillus subtilis cells and 
colonies. 
Hoefler et al., 2013 
Streptomyces sp. PRh5 An endophyte isolated from wild 
rice root. 
Yang et al., 2014 
Streptomyces violaceusniger
 SPC6  
Tolerant to multiple stresses. 
Small genome. 
Chen et al., 2013 
Streptomyces  
viridochromogenes Tu57  
Produces the oligosaccharide 
antibiotic avilamycin. 
Grüning et al., 2013 
Streptomyces viridosporus  
T7A  
Degrades lignin. Davis et al., 2013 
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2.2.1 Streptomyces coelicolor 
S. coelicolor is involved in breaking down organic material in the soil. It is similar to fungi in 
its structure and can adapt to environmental stress. Its potential to cause disease in humans, 
plants, or animals has not been reported. This bacterium has a very similar core genome to 
Mycobacterium tuberculosis and Corynebacterium diphtheriae, as well as some similarity to 
Mycobacterium leprae, being members of the same taxonomic order Actinomycetales 
(Bentley et al., 2002a). It comprises a wealth of genes, allowing the organism a more complex 
life cycle, which allows it to adapt to a wider range of environmental conditions and exploit a 
greater variety of nutrient sources. It is responsible for producing most of the antibiotics in use 
today, as well as some immunosuppressant and anti-tumour agents. This organism produces 
not only antibiotics (Chater and Merrick, 1979:97-98), but also other secondary metabolites, 
including siderophore pigments and lipids. Figure 2.3 illustrates antibiotics (a), siderophores 
(b), pigments (c), lipids (d), and other molecules (e) grouped according to their putative 
function (Bentley et al., 2002a). S. coelicolor has also been used in genetic engineering studies 
to express gene clusters of secondary metabolites (Bilyk et al., 2013, Gomez-Escribano and 
Bibb, 2011). 
 




Figure 2. 3. Secondary metabolites known or assumed to be made by S. coelicolorA3. (taken 
from Bentley et al., 2002a) 
 
2.2.2 Streptomyces avermitilis  
S. avermitilis was isolated from a soil sample collected in Shizuoka Prefecture, Japan in 1978 
by one of the screening programs for the discovery of antiparasitic metabolites (Burg et al., 
1979). It is found in terrestrial soils. Its sporophores form spiral side branches on aerial mycelia. 
They form conidial spores during their life cycle (Witt and Stackebrandt, 1990). S. avermitilis 
produces certain secondary metabolites, namely avermectin, which is a potent agent against a 
wide array of nematodes and arthropods parasites (Burg et al., 1979, Gao et al., 2009, MacNeil 
et al., 1992). The complete genome sequence was described by Ikeda et al. (2003), who found 
the strain S. avermitilis MA-4680 to be 9.0 Mega base pairs (Mbp) in size. Genome availability 
is significant, as it allows for comparison of pathogen sequences and secondary metabolite 
producers within the Actinobacteria. Genome mining of S. avermitilis revealed that this 
organism has at least 38 secondary metabolic gene clusters for at least eight non-ribosomal 
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peptides, six terpenoids, and assorted pigments; osmolytes, siderophores, and bacteriocins were 
identified (Ikeda et al., 2003). Emamectin (Figure 2.4) which is a derivative of avermectin B1 
(Figure 2.4) (Bentley et al., 2002b), has also been described.  
 
Figure 2. 4. Chemical structure of avemectin and emamectin (taken from Bently et al., 2002b).  
 
2.2.3 Streptomyces griseus 
S. griseus produces streptomycin (Ohnishi et al., 2008), a broad-spectrum antibiotic that has 
been used for the treatment of various diseases, such as tuberculosis and the plague, caused by 
Yersinia pestis (Distler et al., 1992). Production of a class III lantipeptide AmfS in S. griseus 
has also been reported (Takano et al., 2017) and the organism has been reported to contain a 
gene cluster that produces fredericamycin, an anticancer drug (Wendt-Pienkowski et al., 2005). 
Genes for streptomycin production in S. griseus were described as well (Mansouri and 
Piepersberg, 1991).  
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2.2.4 Streptomyces bingchenggensis 3 
S. bingchenggensis was isolated in Harbin, China from a soil sample. It produces anthelmintic 
macrolide compounds, which are widely used in the agricultural industry. S. bingchenggensis 
also produces other commercial products, such as milbemycins, a family of macrolide 
antibiotics used in veterinary medicine and crop protection. In addition, polyether 
nanchangmycin and cyclic pentapeptides are examples of other natural products made by 
S.  bingchenggensis (Wang et al., 2013). Its complete genome sequence has been described 
(Wang et al., 2010). 
It has a sequenced genome of 11 936 683 bp, which is longer than the other genomes 
such as S. avermitilis MA-4680 with 9.0 Mbp (Ikeda et al., 2003), followed by S. coelicolor 
A3 with 8.7 Mbp (Bentley et al., 2002a) and S. griseus with 8.5 Mbp (Ohnishi et al., 2008). 
This is regarded as huge coding potential. S. bingchenggensis has a huge number of protein-
coding genes and a large number of transport proteins (Zhou et al., 2016b), which make 
compounds that are important for metabolism and enable their adaptation to complex 
environments. 
Some of its proteins, namely bingchamides A (1) and B (2), isolated from the organic 
extracts of the mycelium, have been found to be cytotoxic to the human colon carcinoma cell 
line HCT-116 (Xiang et al., 2009). In addition to this antitumour activity, compounds with 
acaricidal and nematocidal activity were further isolated (Xiang et al., 2009). Other additional 
products, such as milbemycins, bingchamides and nanchangmycin produced by 
S.  bingchenggensis, were also identified (Wang et al., 2015b).  
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2.2.5 Streptomyces albus J1074 
S. albus J1074 is described as a derivative of S. albus G, because of the absence of restriction
and modification enzymes of the SalI system (Chater and Wilde, 1976) The S. albus J1074 
strain is one of the most widely used strains for the heterologous production of bioactive natural 
products. It was discovered that, because of its fast growth and genetic system, this strain can 
be an attractive model for expressing undiscovered biosynthetic pathways to aid in drug 
discovery (Zaburannyi et al., 2014). It produces versatile secondary metabolites ranging from 
marine micromonospora secondary metabolites to potent anticancer agents.  
2.2.6 Streptomyces rapamycinicus 
During a screening for antifungal compounds, S. rapamycinicus was eventually isolated 
from a soil sample collected from Rapa Nui (Easter Island) (Baranasic et al., 2013). It was 
previously classified as S. hygroscopicus (Kumar and Goodfellow, 2008, Sehgal et al., 1975) 
and is often referred to in literature as ATCC 29253. So far it is the only organism known to 
produce rapamycin, which was initially isolated as an antifungal agent (Sehgal et al., 1975). 
However, it proved to be a potent inhibitor of the mTOR (“target of rapamycin”) signalling 
pathway in mammalian cells, which groups it with a wide range of potential clinical 
applications (Alayev and Holz, 2013). This compound is used as immunosuppressant in renal 
transplants. S. rapamycinicus also produces azalomucin C, a macrodiolide antibiotic used as 
anthelmintic in animal feed (Baranasic et al., 2013). This compound is used as an 
immunosuppressant in renal transplants. It is also used for the prevention of restenosis after 
stent insertion for the treatment of coronary heart disease (Slavin et al., 2007). A second gene 
cluster, similar to the rapamycin gene cluster, has also been reported in the strain (Ruan et al., 
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1997). It has a large genome of 12.7 Mb, of which over 3 Mb consists of 48 secondary 
metabolite biosynthesis clusters (Baranasic et al., 2013). 
2.2.7 Streptomyces albulus NK660 
This strain was isolated from Gutian, Fujian Province, China. It produces ε-Poly-L-lysine 
(ε- PL). ε-PL exhibits antimicrobial activity against a wide spectrum of microorganisms, 
including Gram-positive and Gram-negative bacteria; it also exhibits anti-phage activity. In 
addition, because of its safety and biodegradability, ε-PL has been used as a food preservative. 
The genome of S. albulus NK660, with a guanine-cytosine (GC) content of 72.32%, comprises 
a 9 360 281-bp linear chromosome and a 12 120-bp linear plasmid (Gu et al., 2014). 
 
2.2.8 Streptomyces lividans  
S. lividans is a Gram-positive, filamentous soil bacterium. With its high GC content, this 
species is known for its genomic plasticity (Volff et al., 1997), which entails large deletions 
and extensive amplifications (Dyson and Schrempf, 1987, Eichenseer and Altenbuchner, 1994, 
Hornemann et al., 1993). S. lividans is used as hosts for the synthesis and secretion of 
homologous and heterologous proteins of industrial interest (Anné et al., 2014, Jayapal et al., 
2007, Sianidis et al., 2006, Valverde et al., 2018, Vierling et al., 2000, Nevalainen and 
Peterson, 2014). 
 
2.2.9 Streptomyces glaucescens  
S. glaucescens is known for its production of tetracenomycin C, tetracenomycin D and 
tetracenomycin E antibiotics (Decker et al., 1993, Thompson et al., 2004). See figure 2.5 below 
for the structure of tetracenomycin. 





Figure 2. 5. Chemical structure of tetracenomycin (taken from Decker et al., 1993). 
 
2.2.10 Streptomyces cyaneogriseus  
This is a thermotolerant bacterium isolated in soil, producing a commercially important 
compound, which has been widely used as a bio-pesticide (Wang et al., 2015a, Li et al., 2019). 
It produces chitosanase enzyme, which allows it to degrade chitosan as a sole carbon source 
(El-Sherbiny, 2011). The organism is known to produce the antibiotic nemadectin (Wang et 
al., 2010). 
  
2.2.11 Streptomyces lydicus  
This bacterium species has been isolated from soil in the United States. S. lydicus produces 
actithiazic acid, natamycin, lydimycin, streptolydigin and1deoxygalactonojirimycin (Atta et 
al., 2015, Gómez et al., 2012). A study demonstrated that S. lydicus can be used as an anti-
fungal plant pathogen (Yuan and Crawford, 1995). It has been shown that S. lydicus WYEC108 
is a strong in vitro antagonist against a variety of fungal plant root rot and white-rot pathogens 
and various wood decay fungi. 
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2.2.12 Streptomyces xiamenensis 
This bacterium has been isolated from mangrove sediments in Xiamen in the Fujian Province 
in China (Xu et al., 2009). It produces the antifibrotic benzopyran compound xiamenmycin 
(Figure 2.6), used for treating fibrotic diseases such as idiopathic pulmonary fibrosis, liver 
cirrhosis, systemic sclerosis, progressive kidney disease and cardiovascular fibrosis (Liu et al., 
2013a, Min-Juan et al., 2016, Yang et al., 2014, You et al., 2013). The assembled genome 
comprises a linear chromosome as a single strand of 5 961 401bp (Lei et al., 2015). Moreover, 
gene clusters for capsimycin and capsimycin B and their derivatives (Figure 2.7) have been 




Figure 2. 6. Chemical structure of xiamenmycins A–D (taken from Lei et al., 2015). 
 





Figure 2. 7. Chemical structure of ikarugamycin (1), capsimycin (2), capsimycin B (3), 
capsimycin C (4), capsimycin D (5), capsimycin E (6), capsimycin F (7), and capsimycin 
G (8) (taken from Yu et al., 2017). 
 
2.2.13 Streptomyces ambofaciens   
S. ambofaciens ATCC 23877 is known to produce two antibiotics: spiramycin, a polyketide 
derivative (Karray et al., 2007), and congocidin (or netropsin) (Juguet et al., 2009). Sequencing 
revealed the presence of a further 23 gene clusters with the potential for production of other 
secondary metabolites such as kinamycins, stambomycins (Figure 2.8) and antimycins 
(Aigle et al., 2014). Another antibiotic, ambobactin (Figure 2.9), was isolated from the 
metabolites of Streptomyces ambofaciens F3 (Wei et al., 2015).  




Figure 2. 8. Chemical structure of stambomycins (taken from Aigle et al., 2013). 
 
 
Figure 2. 9. Chemical structure of ambobactin antibiotic (taken from Wei et al., 2015). 
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2.2.14 Streptomyces pristinaespiralis  
S. pristinaespiralis produces two chemically diverse antibiotics: the cyclohexadepsipeptide 
pristinamycin I (PI) and the polyunsaturated macrolactone pristinamycin II (PII) (Figure 2.10). 
PI and PII are coproduced in a 3:7 ratio (Mast and Wohlleben, 2014). In combination, the 
pristinamycins exhibit strong synergistic antibacterial activity against a wide range of Gram-
positive bacteria, including methicillin-resistant staphylococci, drug-resistant Streptococcus 
pneumoniae and vancomycin-resistant Enterococcus faecium (Qadri et al., 1997) and some 
Gram-negative bacteria such as Haemophilus spp. (Mast et al., 2011). 
                   
Figure 2. 10. Chemical structure of pristinamycin I (a) and pristinamycin II (b) (taken from 
Mast et al., 2011). 
 
2.2.15 Streptomyces globisporus 
S. globisporus produces the antitumour angucyclines landomycin A (LaA) and landomycin E 
(LaE) (Rebets et al., 2003) (Figure 2.11). S. globisporus encodes genes for production of the 
enediyne antitumour antibiotic C-1027 (Liu and Shen, 2000).  





Figure 2. 11. Chemical structure of landomycins (taken from Rebets et al., 2003). 
 
2.2.16 Streptomyces scabiei 
This bacterium is found in soil around the world. It is a plant pathogen responsible for the 
formation of lesions on tuber and root crops, as well as decreasing the growth of their seedlings 
(Song et al., 2004). Along with other closely related species, it causes the potato disease 
common scab (Braun et al., 2017, Khatri et al., 2010). S. scabies can produce several related 
toxins that are responsible for its pathogenicity (Lerat et al., 2009).   
 
2.2.17 Streptomyces sp. SirexAA-E 
Streptomyces sp. SirexAA-E is an aerobic microbe that has the capacity to hydrolyse complex 
carbohydrates such as cellulose and hemicellulose (Book et al., 2014, Takasuka et al., 2013). 
This aerobic microbe is a prominent member of a bacterial/fungal symbiotic community and is 
often associated with the invasive woodwasp Sirex noctilio (Takasuka et al., 2013). 
Streptomyces sp. SirexAA-E is responsible for the secretion of enzymes such as endocellulase, 
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exocellulases, hemicellulases, pectinases, and polysaccharide monooxygenases (Takasuka et 
al., 2013) and β-mannanase (Takasuka et al., 2014) 
 
2.2.18 Streptomyces violaceusniger 
S. violaceusniger strain SPC6, isolated from the Linze Desert in China, is a halotolerant 
microorganism. This halotolerant strain can survive in conditions of high salinity (up to 1M 
sodium chloride). In addition, the strain is remarkably resistant to osmotic, heat and ultraviolet 
stress compared with other Streptomyces species. S. violaceusniger strain SPC6 has a very high 
growth rate and short life cycle compared with other Streptomyces species, including the model 
organism, S. coelicolor. It can produce antibiotics that inhibit the growth of other bacteria. The 
draft genome of S. violaceusniger strain SPC6 consists of one chromosome of 6 457 341 bp 
with 73.37% GC content (Chen et al., 2013). 
Hayakawa and colleagues (Hayakawa et al., 2004) conducted a study and discovered 
spores of the S. violaceusniger cluster strains that were resistant to phenol; about 10–80% of 
the spore populations survived. In the same study, 100% of the S. violaceusniger isolates 
demonstrated broad antimicrobial spectra, as they inhibited the growth of all the tested Gram-
positive bacteria (Bacillus. subtilis, Micrococcus luteus, Streptomyces murinus and Staph. 
aureus), yeasts (Candida albicans and Saccharomyces cerevisiae) and filamentous fungi 
(Aspergillus niger, Aspergillus oryzae and Penicillium chrysogenum), while 43% 
S. violaceusniger isolates inhibited Gram-negative bacteria. S. violaceusniger-cluster isolates 
were also found to have an excellent ability against carcinoma cells. 
One strain, S. violaceusniger YCED-9, has been shown to produce at least three 
different antifungal antibiotics, including nigericin, geldanamycin, and a polyene-like 
compound similar to guanidylfungin A (Trejo-Estrada et al., 1998). Another strain, 
S.  violaceusniger WYE53, also expresses strong antibiotic activities against turfgrass fungal 
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pathogens, including Pythium ultimum, Fusarium oxysporium, Rhizoctonia solani, Sclerotina 
homeocarpa, Gaeumannomyces graminis and Microdochium nivale. These fungi cause 
diseases in golf course turfgrass; the S. violaceusniger strains WYE53 and YCED-9 were found 
to be effective in controlling these diseases (Chamberlain and Crawford, 2000). 
 
2.2.19 Streptomyces cattleya NRRL 8057 = DSM 46488 
S. cattleya is a producer of the antibiotics thienamycin (Figure 2.12) (Núñez et al., 2003) and 
cephamycin C (Bushell and Fryday, 1983, Khaoua et al., 1991). It is one of the rare bacteria 
known for the production of fluorinated metabolites. Its genome consists of two linear replicons 
(Barbe et al., 2011). The genes involved in fluorine metabolism and in the biosynthesis of 
antibiotics such as thienamycin and penicillin were mapped (Barbe et al., 2011, Huang et al., 
2006). Through sequencing, the genome of S. cattleya NRRL 8057 was found to comprise one 
linear chromosome SCAT, which is 6 283 062 bp long and has 72.94% GC content and one 
linear megaplasmid pSCAT, which is 1 809 491 bp long and has 73.21% GC content. Six rRNA 
operons, 64 tRNA genes and 5 779 protein-coding genes were also found on the chromosome 
(Barbe et al., 2011). 
 
  
Figure 2. 12. Chemical structure of thienamycin (taken from Núñez et al., 2003). 




2.2.20 Streptomyces hygroscopicus subsp. jinggangensis 5008 
S. hygroscopicus subsp. jinggangensis 5008 (S. hygroscopicus 5008 hereafter), isolated from 
the Jinggang Mountain area of China in 1974 (Xia and Jiao, 1986) produces at least two 
antibiotics of agricultural importance, jingangmycin (Figure 2.13) and jingsimycin. 
Jingangmycin is a weakly basic water-soluble aminocyclitol antibiotic, which was later proven 
to be identical to validamycin. Jingangmycin has been widely used in agriculture for the control 
of sheath blight disease of rice plants and damping-off of cucumber seedlings. Meanwhile, its 
transformed product, valienamine, is a pharmaceutically important precursor for the synthesis 
of voglibose, a highly effective drug for insulin-independent diabetes (Matsumoto et al., 1998). 
The other antibiotic, jingsimycin, is an acidic polypeptide similar to saramycetin and is active 
against various fungi. The 10 383 684-bp genome of S. hygroscopicus 5008 was completely 
sequenced. It is composed of a linear chromosome, a 164.57-kb linear plasmid, and a 73.28-kb 
circular plasmid (Wu et al., 2012). S. hygroscopicus 5008 was also found to produce antibiotic 
valindamycin, which is similar to jingangmycin (Tan et al., 2013). See Figure 2.13 for the 
structure of jingangmycin. 
 
Figure 2. 13. Chemical structure of jingangmycin (taken from 
http://www.rayfull.com/Productshows.asp?ID=15#.WKBk8lV97IU). 
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2.2.21 Streptomyces hygroscopicus subsp. jinggangensis TL01 
This species produces antimycin A. Antimycin A is widely used as a pesticide in the catfish 
farming industry and also has potent killing activity against insects, nematodes and fungi 
(Seipke and Hutchings, 2013). See figure 2.4 below for the chemical structure of antimycins. 
 
Figure 2. 14. Chemical structure of antimycins (taken from Seipke and Hutchinhs, 2013). 
 
2.2.22 Streptomyces venezuelae 
The organism was isolated from a soil sample in Venezuela. Chloramphenicol is produced by 
several Gram-positive soil actinomycetes, but its biosynthesis has been analysed mostly in the 
S. venezuelae strain (Vining and Stuttard, 1995). Chloramphenicol, initially called 
chloromyeetin, was first isolated in S. venezuelae (Ehrlich et al., 1947). Another type of 
antibiotic, jadomycin, is also produced by S. venezuelae ATCC 10712 (Ehrlich et al., 1947). 
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See figure 2.15 below for the chemical structure of chloramphenicol and jadomycin (Sekurova 
et al., 2016). 
Figure 2. 15. Chemical sructure of antibiotics produced by S. venezuelae (taken from Sekurova 
et al., 2016). 
2.2.23 Streptomyces davawensis 
This non-pathogenic Gram-positive soil bacterium produces the riboflavin analogs roseoflavin 
and 8-demethyl-8-amino-riboflavin (Figure 2.16) (Otani et al., 1974). Both compounds show 
antimicrobial activity against Gram-positive bacteria such as Bacillus subtilis, but also against 
Gram-negative bacteria if uptake systems for flavins/flavin analogs are present (Grill et al., 
2007). 
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Figure 2. 16. Chemical structure of rivoflavin analogs (taken from Otani et al., 1974). 
 
2.2.24 Streptomyces albus DSM 41398 
S. albus DSM 41398 produces the antibiotic salinomycin (Jiang et al., 2007, Yurkovich et al., 
2012). Salinomycin has selective activity against cancer (Kim et al., 2014, Mai et al., 2017), 
as well as therapy-resistant cancer cells (Dewangan et al., 2017). However, it has been widely 
used as veterinary medicine in animal husbandry as food additive and growth promoter for 




Figure 2. 17. Chemical structure of salinomycin (taken from Jiang et al., 2015). 
 
2.2.25 Streptomyces sp. PAMC 26508 
Streptomyces sp. PAMC 26508 was isolated from the Antarctic lichen Cladonia borealis. This 
endosymbiotic bacterium has a 7 526 197 bp linear chromosome with 70.89% GC content, and 
one plasmid with 104 048 bp. It has demonstrated antibacterial activities in different studies 
(Shin et al., 2013). In one such study, the strain showed antibacterial activity against all target 
bacteria (Kim et al., 2014).  
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2.2.26 Streptomyces fulvissimus 
The S. fulvissimus genome consists of a single linear chromosome of 7 905 758 bp (71.5% GC 
content) with no plasmids. Analysis of the genome sequence indicated the presence of 32 
putative gene clusters involved in the biosynthesis of different natural products (Myronovskyi 
et al., 2013). S. fulvissimus was found to secrete an antibacterial protein inhibitory to 
Micrococcus luteus, Bacillus. subtillis, Bucillus. cereus, and methicillin resistant 
Staphylococcus aureas strains (Malik et al., 2008). 
 
2.2.27 Streptomyces collinus 
S. collinus was isolated in 1972 from Kouroussa (Guinea). It is best known as producer of the 
antibiotic kirromycin, an inhibitor of the protein biosynthesis interacting with elongation factor 
EF-Tu (Rückert et al., 2013). Additional products produced by this bacterium were discovered; 
genome mining revealed 32 gene clusters encoding the biosynthesis of diverse secondary 
metabolites in the genome of S. collinus Tü 365 (Iftime et al., 2016). Figure 2.18 below 
indicates secondary metabolites produced by this strain. 




Figure 2. 18. Structures of identified and predicted secondary metabolites encoded in 
S. collinus Tü 365 genome (taken from Iftime et al., 2015). 
 
2.2.28 Streptomyces albulus ZPM 
S. albulus ZPM was isolated from the soil of Zi-Peng Mountain, west of Hefei, China using 
the methylene blue screening method. It produces the homopolymer antibiotic, ε-poly-lysine 
(ε-PL) (Wibowo et al., 2013). The complete genome sequence of S. albulus ZPM revealed a 
single linear chromosome composed of 9 784 577 bp, with the pZPM234 plasmid and an 
average G+C content of 72.2%. Analysis revealed 44 gene clusters for secondary metabolites 
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in S. albulus ZPM (Wang et al., 2015b). See figure 2.19 below for the chemical structure of 
the antibiotic ε-PL. 
 
Figure 2. 19. Chemical structure of ε-poly-lysine (taken from Yoshida and Nagasawa, 2003). 
 
2.2.29 Streptomyces vietnamensis 
S. vietnamensis was isolated from a forest soil sample in Vietnam. It is an aerobic that is Gram-
positive and catalase-positive and forms a white aerial mycelium and a reddish-brown substrate 
mycelium. In a study conducted, no antibacterial activity was evident against Escherichia coli, 
Pseudomonas aeruginosa, Bacillus. subtilis, Candida. albicansor or Penicillium citrinum (Zhu 
et al., 2007). However, its production for industrial violet-blue pigment has been explored 
(Deng et al., 2011). 
 
2.2.30 Streptomyces sp. Mg1 
Streptomyces sp. Mg1 produces the macrolide antibiotic chalcomycin A, which has been found 
to inhibit growth of B. subtilis cells (Barger et al., 2012). It causes lysis and degradation of 
B. subtilis and its colonies. Genome sequencing revealed that Streptomyces sp. Mg1 has 8.7 Mb 
genome (Hoefler et al., 2013). See Figure 2.20 for the structure of chalcomycin A. 
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Figure 2. 20. Chemical structure of chalcomycin A (taken from Barger et al., 2012). 
2.2.31 Streptomyces sp. CNQ-509 
 This is a marine-derived strain, isolated from a near-shore marine sediment off La Jolla, 
Califonia in 2001 (Prieto-Davó et al., 2008). Compounds such as naphterpin (Gallagher et al., 
2010), debromomarinone (Pathirana et al., 1992), nitropyrrolins (Kwon et al., 2010), 
naphthoquinone (Park and Kwon, 2018) and marinophenazines (Espindola, 2008) have been 
isolated from this strain. Its complete genome sequence has been described (Rückert et al., 
2015). See Figure 2.21 for the metabolite structures produced by the strain (Leipoldt et al., 
2015). 
Figure 2. 21. Secondary metabolites produced by Streptomyces sp. CNQ 509 (taken from 
Leipoldt et al., 2015). 
This species contains 29 putative gene clusters for the biosynthesis of secondary 
metabolites, some of them potentially involved in the formation of meroterpenoid molecules. 
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Streptomyces sp. CNQ-509 is a remarkable producer of various terpenoid compounds (Leipoldt 
et al., 2015).  
2.2.32 Streptomyces sp. CFMR 7 
Streptomyces sp. strain CFMR 7, which naturally degrades rubber (Chia et al., 2014), was 
isolated from a rubber plantation in Penang, Malaysia. Whole genome sequencing and 
assembly resulted in two contigs with a total genome size of 8.248 Mb (Nanthini et al., 2015). 
It has also been found to degrade latex gloves, latex condoms and latex car tyres (Nanthini and 
Sudesh, 2017). 
2.2.33 Streptomyces sp. CdTB01 
Streptomyces sp. strain CdTB01 was isolated from soil contaminated with heavy metals. The 
strain demonstrates tolerance to high concentrations of heavy metals, particularly cadmium. 
Two contigs with a total genome size of 10.19 Mb were identified in the whole genome 
sequencing and assembly (single circular chromosome of 9 902 731 bp and linear plasmid of 
288 836 bp). Numerous homologous genes known to be involved in heavy metal resistance 
were also found in the genome (Zhou et al., 2016a). 
2.2.34 Streptomyces reticuli 
The bacterium S. reticuli is known for its production of an unusual mycelia-associated cellulase 
(avicelase) (Schlochtermeier et al., 1992), which can degrade crystalline cellulose to cellobiose 
(Schrempf and Walter, 1995). It consists of a linear 8.3 Mb chromosome, a linear 0.8 Mb 
megaplasmid, a linear 94 kb plasmid and a circular 76 kb plasmid (Wibberg et al., 2016). 
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2.2.35 Streptomyces sp. 4F 
Streptomyces sp. 4F was isolated from the soil in China. It is one of the fast-growing and 
moderately thermophilic (growing at both 30°C and 50°C) Streptomyces strains (Chen and Qin, 
2011). This characteristic has led to its use in antibiotic expressions (Chen and Qin, 2011) and 
DNA assembly (Chen et al., 2013). 
 
2.3 Introduction to cytochrome P450 monooxygenases  
Cytochromes P450 monooxygenases (CYPs/P450s) are found throughout all the biological 
kingdoms of life. They belong to the superfamily of proteins containing a heme cofactor, 
making them hemoproteins. P450s are also referred to as mixed function oxidases; they can 
catalyse a variety of enzymatic reactions and transform endogenous chemicals into more polar 
and/or detoxified derivatives (Bernhardt, 2006, Isin and Guengerich, 2007, Sono et al., 1996). 
They derive their name from a distinctive characteristic of being bound to membranes within 
a cell (cyto) and containing a heme pigment (chrome and P) that absorbs light at a wavelength 
of 450 nm when exposed to carbon monoxide (Figure 2.22) (Guengerich et al., 2009). The 
absorption was discovered in 1958 as an unusual spectrum taken from rat liver microsomes 
with a peak of absorbance at 450 nm (Klingenberg, 1958). In 1962, it was proved that CYP 
was a terminal oxidase by showing the ability to catalyse the C21 hydroxylation of 17-
hydroxyprogesterone in adrenal cortical microsome (Estabrook et al., 1963).  




Figure 2. 22. Typical cytochrome P450 monooxygenase ferrous-CO versus ferrous-difference 
spectrum (taken from Guengerich et al., 2009). 
 
Monooxygenase reaction is the most common example of a reaction carried out by a 
cytochrome P450 enzyme; in the reaction, one atom of oxygen is inserted into the aliphatic 
position of an organic substrate [RH] and the other atom is reduced to water, as in the reaction 
below:  
 
NADPH + H+ + O2
 + RH →NADP+ + H2O + ROH 
 
In these reactions, RH represents an oxidisable drug substrate and ROH is the hydroxylated 
metabolite.   
 
2.4 Applications of P450s 
One of the surprising discoveries about the genomics of the P450 superfamily is the large 
number of P450s in the bacterial phyla Actinobacteria (Parvez et al., 2016). It has been 
suggested that this large number is promising in terms of their properties and potential 
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applications in the industry (Notonier et al., 2016). Most of those identified so far are generally 
involved in either biotransformation reactions, e.g. S. griseolus is involved in the metabolism 
of sulfonylurea herbicides to less toxic derivatives through its P450 CYP105A1 (O'Keefe et 
al., 1988), or are part of specialised metabolite biosynthetic pathways, e.g. CYP170B1 
catalyses production of the albaflavenone in S. albus (Moody et al., 2012).  
 
In humans they are a major class of biocatalyst involved in the oxidative metabolism 
of exogenous as well as endogenous compounds, including drugs, xenobiotics, fatty acids, bile 
acids and steroids. Numerous P450 applications have also been thoroughly reviewed elsewhere 
(Greule et al., 2018, Guengerich, 2002, Urlacher and Eiben, 2006, Zhang et al., 2011). Figure 
2.23 (Kelly and Kelly, 2013) illustrates areas of application for microbial P450. 
 
  
Figure 2. 23. Areas of application for microbial CYPs and reactions associated with them 
(taken from Kelly and Kelly, 2013). 
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Many of the bacterial P450s catalyse reactions of environmental or medical 
significance. Their capability to metabolise thousands of endogenous and exogenous chemicals 
has led to discovered characteristics that account for their central importance in medicine. Their 
enzyme family is capable of catalysing the oxidative biotransformation of most drugs and other 
lipophilic xenobiotics (Guengerich, 2007, Foti et al., 2011) and they have been implicated in 
the biotransformation of most foreign substances, including 70% to 80% of all drugs in clinical 
use (Zanger and Schwab, 2013). For instance, in the drug discovery and development category, 
one well-established commercial application of P450 monooxygenases is the 
biotransformation of steroids to drugs, such as 11β- hydroxylation of reichstein S to 
hydrocortisone (van Beilen et al., 2003). Thus P450s are regarded as the major enzymes 
involved in drug metabolism, accounting for about 75% of the total metabolism (Guengerich, 
2007). Even though there are more than 50 CYP450 enzymes, CYP1A2, CYP2C9, CYP2C19, 
CYP2D6, CYP3A4, and CYP3A5 enzymes are known to metabolize 90% of drugs (Slaughter 
and Edwards, 1995, Wilkinson, 2005). P450s can also deactivate drugs directly or such drugs 
can be deactivated through facilitated excretion from the body. Furthermore, many substances 
are bio-activated by P450s to form their active compounds (van Beilen et al., 2003). Drugs are 
not the only compounds metabolised by P450s; products of endogenous metabolism, such as 
bilirubin, are metabolised in the liver by P450s as well (Abu-Bakar et al., 2012). P450s are also 
involved in the conversion of progesterone to cortisone (Peterson et al., 1957) and 
hydroxylation of steroids (Niwa et al., 2015, Zehentgruber et al., 2010). 
Being mostly present in tissues of the body, P450s also play important roles in synthesis 
and breakdown of hormones, such as steroid hormone synthesis and metabolism (Davies et al., 
1999, Parker and Schimmer, 1995), cholesterol synthesis (Payne and Hales, 2004), vitamin D 
metabolism and the beneficial conversion of codeine into morphine (Stefano et al., 2012). They 
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are also involved in the nitration of tryptophan to form thaxtomin A by CYP1048A1 
from S. scabiei and other Streptomyces species (Girvan and Munro, 2016). Another classical 
example is aspirin, a commonly used non-steroidal anti-inflammatory drug. Aspirin is 
metabolised by CYP2C8 and CYP2C9 (Preissner et al., 2012). Yet at the same time human 
P450s are the basis for sometimes fatal drug interactions (Guengerich, 2006, Lynch and Price, 
2007).  
Detection of drugs (clozapine), xenobiotic compounds (styrene) and fatty acids 
(cholesterol) was made possible by the development of biosensors based on mammalian P450 
(CYP1A2, CYP2B4 and CYP11A) models (Paternolli et al., 2004). Moreover, biofuel 
production (Zhang et al., 2011, Koch et al., 2009) from alkanes or fatty acids has been explored 
using engineered bacterial P450s, CYP153A6 and OleTJE (a P450 from the CYP152 family) 
(Matthews et al., 2017, Rude et al., 2011) to make then valuable industrial compounds. To 
expand their substrate range for further potential applications, bio-engineering of model 
bacterial P450s CYP101 and CYP102 has been attempted in several studies (Carmichael and 
Wong, 2001, Jones et al., 2001, Sulistyaningdyah et al., 2004), and strategies for P450 
recombinant expression are being investigated (Hausjell et al., 2018). 
While other P450s can render pesticides inactive, some of them are targets for anti-
fungals. Still others make key antibiotics such as vancomycin (Cryle et al., 2010), antimalarials 
such as artemisinin (Ro et al., 2006) and anti-cancer drugs such as taxol (Jennewein et al., 
2001). Production of macrolide antibiotic erythromycin and vancomycin by the use of 
P450eryF (CYP107A1) from Saccharopolyspora erythraea (Andersen et al., 1993) and P450 
OxyA, OxyB and OxyC from Amycolatopsis orientalis (Bischoff et al., 2005) has been 
reported. CYP725A1 from yew (Taxus cuspidate) (Jennewein et al., 2005) and CYP153 from 
Mycobacterium sp. (van Beilen et al., 2005) have been used in biosynthesis of the anticancer 
drugs taxol and perillyl alcohol. Work by Tian et al. ( 2015) demonstrated that P450 107U1 is 
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required for sporulation and antibiotic production in S. coelicolor. Since then research on 
functional and structural analysis of P450s (Guengerich et al., 2016, Sirim et al., 2010) and 
their significance in the drug industry (Manikandan and Nagini, 2018) has continued. 
Many laboratories that do not have access to human P450s use Streptomyces 
species to test drugs. Streptomyces species are used in drug-testing studies because of 
functional similarities of human P450 and Streptomyces P450s and therefore these methods are 
frequently used to mimic human drug metabolism studies (Lamb et al., 2013). Table 2.2 shows 
the similar enzymatic reaction catalysed by human and Streptomyces species P450s.  
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Table 2. 2. Selected examples of drugs, the individual human P450 enzymes involved in their 
metabolism, the specific Streptomyces strain used to generate metabolites and the associated 
P450 reactions observed (taken from Lamb et al., 2013). 
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Deriving information about an organism through genome mining has appeared to be a 
promising tool (Du and van Wezel, 2018, Ziemert et al., 2016). Predictions of gene functions 
became possible as genome analysis was done on sequenced strains (Hadjithomas et al., 2015).  
Mining work has since been done on some species, such as Streptomyces 
chattanoogensis L10 (CGMCC 2644) (Zhou et al., 2016b), Streptomyces collinus Tü 365 
(Iftime et al., 2016) and Streptomyces sp. YIM 130001 (Schneider et al., 2018). Complete gene 
clusters for Streptomyces sp. have so far been identified in the Atlas of Biosynthetic Gene 
Clusters (Hadjithomas et al., 2015). Streptomyces species thus show great promise as catalytic 
tools, even though only a few Streptomyces P450s have been functionally and structurally 
characterised to date (Rudolf et al., 2017). P450 are also known for their evolutionary characteristic 
behaviour. The adaptational changes to P450 and blooms in their linages due to evolution have 
already been observed in other organisms (Córdova et al., 2017, Feyereisen, 2011, Syed and 
Mashele, 2014) as well as in vertebrates and invertebrates (Kawashima and Satta, 2014). 
Understanding of their evolutionary mechanisms will assist in revealing important aspects to exploit 
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3.1 Streptomyces species and genome databases 
Forty-eight Streptomyces species of genomes that are available for public use at Integrated 
Microbial Genomes and Microbiomes from the Joint Genome Institute 
(https://img.jgi.doe.gov/) and Kyoto Encyclopedia of Genes and Genomes (KEGG) (Kanehisa 
et al., 2015) were used in this study. Detailed information on species used in this study, along 
with their genome database links and genome IDs, are listed in Table 3.1.  
3.2 Genome data-mining and identification of P450s 
Streptomyces species genomes that are publicly available as listed in Table 3.1 were mined for 
P450s following the method described elsewhere (Mthethwa et al., 2018, Ngwenya et al., 2018, 
Parvez et al., 2016). Briefly, for each bacterium, whole proteomes were downloaded and 
grouped into different protein families using the National Centre for Biotechnology and 
Information (NCBI) Conserved Domain Database: NCBI Batch Web CD-search tool 
(Marchler-Bauer et al., 2016). The hit proteins grouped under the cytochrome P450 
monooxygenases superfamily were selected for further study. The bacterial genome available 
at Integrated Microbial Genomes and Microbiomes from the Joint Genome Institute was mined 
for P450s using InterPro code “IPR001128”. The hit protein sequences were downloaded and 
subjected to the NCBI Batch Web CD-Search Tool (Marchler-Bauer et al., 2016). Proteins that 
grouped under the P450 superfamily were selected for further analysis. The selected proteins 
were searched for the presence of P450 characteristic motifs such as EXXR and CXG. Proteins 
having one of the motifs were considered as fragment/pseudo-P450s. For each organism, P450s 
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identified at KEGG and Integrated Microbial Genomes and Microbiomes were compared. A 
final total count is presented by deleting the same P450s found in both genome databases.     
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Table 3. 1. List of Streptomyces species used in the study. Species names, codes, the respective genome database links and genome IDs from 
NCBI were listed in the table. 
Species name Species code Database link Genome ID 
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Streptomyces cattleya NRRL 






pratensis/flavogriseus IAF 45 
Sfa http://www.genome.jp/kegg-bin/show_organism?org=sfa  CP002475 





subsp. jinggangensis 5008 
Shy http://www.genome.jp/kegg-bin/show_organism?org=shy  CP003275 
Streptomyces hygroscopicus 
subsp. jinggangensis TL01 
Sho http://www.genome.jp/kegg-bin/show_organism?org=sho  CP003720 
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Spri http://www.genome.jp/kegg-bin/show_organism?org=spri CP011340 
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Streptomyces lincolnensis Sls http://www.genome.jp/kegg-bin/show_organism?org=sls CP016438 
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3.3 Assigning P450 family and P450 subfamily to orphan P450s 
The above selected P450s were subjected to Basic Local Alignment Search Tool (BLAST) 
analysis against all named bacterial sequences on the Cytochrome P450 Homepage (Nelson, 
2009) to identify the closest named homolog P450. Based on the percentage identity to the 
named homolog P450, i.e. >40% amino acid identity and >55% amino acid identity, P450s 
were grouped under the same family and same subfamily (Nelson, 2006). P450s that had less 
than 40% and 55% amino acid identity to the named homolog P450s were assigned to new 
P450 families and new P450 subfamilies. Some Streptomyces species P450s were annotated 
and made available at the Cytochrome P450 Homepage (Nelson, 2006). In this case, the same 
nomenclature for P450s was continued. The Streptomyces P450 protein sequences along with 
their names were available as Dataset 1 at https://www.nature.com/articles/s41598-019-40646-
y#Sec19. For comparative analysis the P450 data for mycobacterial species were retrieved from 
published literature (Parvez et al., 2016).  
3.4 Construction of the P450s phylogenetic tree 
The phylogenetic tree of P450s was constructed as described previously (Chen et al., 2014). 
First, the P450 protein sequences were aligned using the HMMER package 3.1b2 
(http://hmmer.org/) by adjusting them to the P450 profile hidden Markov model PF00067 from 
the Pfam database (http://pfam.xfam.org/) (Finn et al., 2015). Then, the phylogenetic tree from 
P450s alignments was generated by FastTree 2.1.10 using the maximum-likelihood method 
(http://www.microbesonline.org/fasttree/) (Price et al., 2010). Finally, the phylogenetic tree 
was displayed by iTOL (http://itol.embl.de/upload.cgi) (Letunic and Bork, 2016). 
© Central University of Technology, Free State
90 
3.5 Analysis of P450 diversity percentage 
The percentage contribution of the number of P450 families in the total number of P450s in an 
organism is considered the P450 diversity percentage (Parvez et al., 2016, Sello et al., 2015). 
This formula was employed previously to measure the P450 diversity percentage among 
species in a genus (Parvez et al., 2016, Sello et al., 2015). However, in order to compare two 
genera of a phylum where the number of species will be different, a new formula (shown 
below) has been formulated to obtain an average P450 diversity percentage per species. 
The above formula will nullify the number of species used and will give an accurate P450 
diversity percentage comparison between the genera within a phylum; previously this was not 
employed (Parvez et al., 2016, Sello et al., 2015). A point to be noted is that this formula is 
useful only when the number of species shared between the genera is relatively similar. For 
comparative analysis the P450 diversity percentage data for mycobacterial species were 
retrieved from published literature (Parvez et al., 2016). 
3.6 Generation of P450 profile heatmaps 
The presence or absence of P450s in Streptomyces species was shown with heatmaps generated 
using P450 family data following the method described elsewhere (Mthethwa et al., 2018). 
Briefly, the data were represented as −3 for family presence (green) and 3 for family absence 
(red). A tab-delimited file was imported into Multi-experiment Viewer (Mev) (Saeed et al., 
2003). Hierarchical clustering using a Euclidean distance metric was used to cluster the data. 
P450 diversity percentage = 
100 x Total number of P450 families 
Total number of P450s x number of species 
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Forty-eight Streptomyces species formed the horizontal axis and CYP family numbers formed 
the vertical axis. 
 
3.7 Functional analysis of P450s 
Considering the large number of P450s identified in this study and the availability of functional 
data for some P450s (Rudolf et al., 2017), a literature survey on the functional analysis of 
Streptomyces species P450s was carried out and used in this study. The functional role of P450s 
in Streptomyces physiology is presented at P450 family level and subfamily level. Furthermore, 
functional analysis of some Streptomyces species P450 was predicted based on the 
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CHAPTER 4 
RESULTS AND DISCUSSION 
4.1 Identification of Streptomyces P450s 
Genome-wide data mining and annotation of P450s in 48 Streptomyces species revealed the 
presence of 1 625 P450s in their genomes (Fig. 4.1 and Table 4.1). Among these 1 625 P450s, 
all had characteristic glutamic acid and cysteine at the EXXR and CXG motifs, respectively; 
however, 34 P450s lacked one or both P450 characteristic motifs, EXXR and CXG, owing to 
short amino acid sequences and were thus regarded as fragment/pseudo-P450s (Table 4.2). The 
presence of short P450s/pseudo-P450s is common in organisms. Two false positive P450 
fragments were identified in S. ambofaciens ATCC 23877 and another one in Streptomyces 
sp. CdTB01. These P450 fragments were not included in the final count. The P450 count in the 
Streptomyces species ranged from 16-69 P450s, with an average of 34 P450s (Fig. 4.2A and 
Table 4.1). Among the Streptomyces species selected for the study, Streptomyces sp. CNQ-509 
and Streptomyces sp. 4F have the lowest number of P450s (16 P450s) and Streptomyces albulus 
ZPM the highest number of P450s (69 P450s) in their genomes (Fig. 4.2A). The percentage 
coverage of P450s in the Streptomyces species ranged from 0.2% to 1.1% in (Table 4.1). 
Comparison of P450s revealed that species belonging to the genera Streptomyces and 
Mycobacterium had almost the same patterns in terms of the average number of P450s in their 
genomes, the highest average percentage contribution of P450s in the genome (≥1%) and 
highest number of P450s for a species (S. albulus ZPM has 69 P450s and M. rhodesiae NBB3 
has 70 P450s). 
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Figure 4. 1. Phylogenetic analysis of Streptomyces P450s. P450 families that are dominant in 
Streptomyces species are highlighted in different colours. 
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Table 4. 1. P450 family and subfamily level comparative analysis of P450s in 48 Streptomyces species. Open reading frames (ORFs) for each 
species were obtained from the genome database listed in Table 3.1. The percentage of P450s was calculated considering ORFs as 100%. 




No. of P450 
families 
No. of P450 
subfamilies 
ORFs % of 
P450s 
Streptomyces albulus ZPM sall 69 27 52 8191 0.8 
Streptomyces albulus NK660     salu 64 27 50 8086 0.8 
Streptomyces noursei Snr 64 26 52 8691 0.7 
Streptomyces violaceusniger Svl 51 16 42 8985 0.6 
Streptomyces bingchenggensis Sbh 50 26 44 10022 0.5 
Streptomyces rapamycinicus         Src 63 23 56 10002 0.6 
Streptomyces cattleya NRRL 8057 = DSM 46488 Scy 42 21 39 7569 0.6 
Streptomyces sp. 769 Stre 59 24 49 9553 0.6 
Streptomyces hygroscopicus subsp. jinggangensis 
5008 Shy 38 18 33 9108 0.4 
Streptomyces cattleya NRRL 8057 = DSM 46488 Sct 41 20 38 7475 0.5 
Streptomyces hygroscopicus subsp. jinggangensis 
TL01 Sho 37 18 33 8878 0.4 
Streptomyces avermitilis sma 53 24 45 7676 0.7 
Streptomyces collinus Sci 34 16 27 7113 0.5 
Streptomyces lydicus Sld 40 19 35 8888 0.5 
Streptomyces sp. Mg1 Strm 37 21 36 7117 0.5 
Streptomyces leeuwenhoekii Sle 36 17 34 7005 0.5 
Streptomyces pratensis Sfa 29 16 26 6572 0.4 
Streptomyces reticuli Srw 47 26 43 8090 0.6 
Streptomyces griseus Sgr 28 13 24 7136 0.4 
Streptomyces sp. PAMC 26508 Strp 29 16 26 7073 0.4 
Streptomyces sp. SirexAA-E Ssx 24 10 22 6357 0.4 
Streptomyces davawensis Sdv 32 19 30 8616 0.4 
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Streptomyces cyaneogriseus Scw 33 16 30 5830 0.6 
Streptomyces lincolnensis Sls 24 15 23 8590 0.3 
Streptomyces pristinaespiralis spri 23 12 18 7352 0.3 
Streptomyces venezuelae Sve 23 16 21 7453 0.3 
Streptomyces sp. CFMR 7 Scz 24 13 20 6716 0.4 
Streptomyces vietnamensis Svt 30 20 29 7356 0.4 
Streptomyces xiamenensis Sxi 20 12 19 5484 0.4 
Streptomyces coelicolor Sco 18 10 17 8152 0.2 
Streptomyces albus J1074 Salb 18 9 18 5832 0.3 
Streptomyces ambofaciens samb# 19 10 18 7793 0.2 
Streptomyces lividans Slv 20 10 18 7360 0.3 
Streptomyces scabiei Scb 30 16 30 8746 0.3 
Streptomyces glaucescens Sgu 18 11 17 6567 0.3 
Streptomyces albus DSM 41398 Sals 25 13 24 7330 0.3 
Streptomyces fulvissimus Sfi 19 10 16 6925 0.3 
Streptomyces sp. CNQ-509 Strc 16 11 16 6407 0.2 
Streptomyces rubrolavendulae Srn 20 12 19 5425 0.4 
Streptomyces clavuligerus sclf 65 30 58 5981 1.1 
Streptomyces griseochromogenes sgs 46 24 40 9064 0.5 
Streptomyces sp. S10(2016) stsi 20 15 20 7661 0.3 
Streptomyces globisporus sgb 23 13 19 6654 0.3 
Streptomyces sp. CdTB01# scx 26 17 25 8743 0.3 
Streptomyces parvulus spav 25 15 25 6714 0.4 
Streptomyces lydicus slc 32 13 29 6872 0.5 
Streptomyces sp. SAT1 strt 25 15 22 6110 0.4 
Streptomyces sp. 4F strf 16 11 15 6792 0.2 
#, Two and one false positives P450 fragments were identified in Streptomyces ambofaciens ATCC 23877 and Streptomyces sp. CdTB01, 
respectively. These P450 fragments were not considered in the final count. 
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    Table 4. 2. Streptomyces species pseudo/fragment P450s. P450s were represented with their 
name following the protein ID (in parenthesis) and species code. 
Fragment/pseudo P450s (34 P450s) Comment 
CYP1453B-fragment(2712578143)SMA NO EXXR 
CYP2340B2P(2712584497)SMA Truncated P450 
CYP178A3P(2712585028)SMA No EXXR 
CYP105B23(2712586946)SMA No EXXR 
CYP107AM-fragment1(646978401)SBH No EXXR 
CYP107AS-fragment1(2511677887)SCT No EXXR and CXG 
CYP107AS(2511977159)SCY No EXXR and CXG 
CYP125A25-fragment(647544071)SCLF No EXXR and CXG 
CYP161F1P(647544976)SCLF Short P450 with EXXR and CXG 
CYP183U1P-N-term(647548353 SCLF No EXXR & N-terminal missing 
CYP183U1P-C-term(647548354)SCLF C-terminal missing
CYP155A-fragment2(2649527539)SCW No EXXR 
CYP155A-fragment1(2649527540 )SCW No EXXR 
CYP152D-fragment1(2649527873)SCW No CXG 
CYP1047B3P(2685041405)SGS No CXG 
CYP125A32(SHJG_3828)shy No EXXR and CXG 
CYP125A32(SHJGH_3593)sho No EXXR and CXG 
CYP125A31(2562375444)SHO No EXXR and CXG 
CYP107L52P(2652740080)SLD No EXXR and CXG 
CYP107CJ2(2652740805)SLD No EXXR and CXG 
CYP183B(2603775408)SNR No EXXR and CXG 
CYP147B6(2603782400)SNR No EXXR 
CYP154D20Pb(2689319916)SRW No CXG 
CYP154D20Pa(2689319917)SRW No EXXR and CXG 
CYP105AC45P(2628747249)STRE No EXXR and CXG 
CYP105AC43P(2628747250)STRE No EXXR and CXG 
CYP183B4P(2628747539)STRE No EXXR 
CYP154D21P(2628749871)STRE No EXXR 
CYP113D4(2628752396 )STRE No EXXR 
CYP105B-fragment(648750691)SVL No EXXR 
CYP107Z26Pa(648758019)SVL No EXXR 
CYP107Z26Pb(648758020)SVL No EXXR and CXG 
CYP1530A3Pb(2688559483)SCX No EXXR 
CYP105Bfragment(2633776877)SXI No EXXR 
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Figure 4. 2. Comparative analysis of P450s in 48 Streptomyces species. (A) Comparative 
analysis of the number of P450s, P450 families and P450 subfamilies in 48 Streptomyces 
species. Each Streptomyces species is presented with its code (for details see Table 4.3). (B) 
P450 family-level comparative analysis in Streptomyces species. P450 families that are 
dominant in Streptomyces species are presented in the figure. The numbers next to the family 
bar indicate the total number of P450s and percentage contribution (parenthesis) by a particular 
family to the total number of P450s (for details see Table 4.5). (C) P450 subfamily-level 
comparative analysis among seven dominant P450 families. The numbers next to bars indicate 
the number of P450 subfamilies in that family. 




4.2 Streptomyces species have more diverse P450s than mycobacterial species  
As per International P450 Nomenclature Committee Rules (Nelson, 2006), all 1 625 P450s 
identified in 48 Streptomyces species were grouped into 144 P450 families and 377 P450 
subfamilies (Fig. 4.2 A and Table 4.3). Among the families and subfamilies, 66 new P450 
families and 144 new P450 subfamilies were identified in Streptomyces species (Table 4.4). 
Most of the new P450 subfamilies were identified in the P450 families CYP107 (62 new 
subfamilies) and CYP105 (38 new subfamilies) (Table 4.4). A detailed list of newly identified 
P450 families and P450 subfamilies in Streptomyces species is presented in Table 4.4. An 
interesting feature observed during phylogenetic analysis of Streptomyces P450s is that some 
P450 family members are not grouped together (Fig. 4.1), despite being annotated according 
to the rules set by the International P450 Nomenclature Committee (Nelson, 2006), suggesting 
that sometimes the phylogenetic-based annotation of P450s could be detecting similarity cues 
beyond a simple percentage identity cut-off. It is especially difficult to assign subfamily 
membership in large families such as CYP105 and CYP107. 
Analysis of P450 family conservation across 48 Streptomyces species revealed that 
among 144 P450 families identified, only two P450 families, the CYP107 and CYP157 P450 
families, are conserved across all Streptomyces species (Fig. 4.3 and Table 4.3). Certain P450 
families, such as CYP105 and CYP156, tend to co-occur in some but not all Streptomyces 
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Figure 4. 3. Heatmap of the presence or absence of P450 families in 48 Streptomyces species. 
Forty-eight Streptomyces species form the horizontal axis (see Table 3.1 for species codes) and 
P450 families (right side) and the phylogenetic relationship among P450 families (left side) 
form the vertical axis. The data have been represented as -3 for family presence (green) and 3 
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for family absence (red). The data used in the generation of the figure are available as Dataset 
2 at https://www.nature.com/articles/s41598-019-40646-y#Sec19. 
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Table 4. 3. Comparative analysis of P450 families in 48 Streptomyces species. 
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Table 4. 4. New P450 families and subfamilies identified in Streptomyces species. 
New families Total number 
CYP1035-CYP1039; CYP1047; CYP1048; CYP1053-
CYP1059; CYP1060-CYP1066;  CYP1189-CYP1194; 
CYP1196-CYP1199; CYP1251; CYP1274; CYP1416-
CYP1420; CYP1422-CYP1424; CYP154; CYP155-CYP159; 
CYP161; CYP1618; CYP170; CYP171; CYP178-CYP184; 
CYP2045; CYP208; CYP2108; CYP211; CYP2189; CYP2238; 
CYP246; CYP282; CYP283 
66 
New subfamilies (144) 
P450 family Total number of new subfamilies Name of the subfamily 
CYP102 2 B, G 
CYP105 38 AT, AU, AV, AW, AX, AY, 
AZ, B, BA, BB, BC, BD, BE, 
BF, BG, BH, BQ, BR, BS, 
BT, BU, BV, BW, D, DB, 
DC, DD, DE, DF, DG, H, M, 
N, P, Q, R, U, Z 
CYP107 62 AD, AK, AL, AM, BK, BW,  
BY, BZ, CD-CH, CJ, CK-CN, 
CP-CW, DU, DW, EA-EH, 
EJ, EK-EN, EP-ER, KW-KZ, 
LA-LG, P, T-Y 
CYP112 1 B 
CYP113 4 G, J, Y, Z 
CYP1222 1 D 
CYP1223 1 B 
CYP123 1 D 
CYP1240 1 B 
CYP135 2 D, G 
CYP136 2 E, F 
CYP143 1 C 
CYP145 3 B, C, D 
CYP147 2 B, K 
CYP152 1 D 
CYP166 1 C 
CYP186 1 D 
CYP251 3 E, F, G 
CYP1005 1 B 
CYP1278 1 B 
CYP1339 1 B 
CYP1341 1 E 
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CYP162 1 C 
CYP163 4 C, D, G, H, 
CYP1995 2 B, C 
CYP199 1 R 
CYP274 2 B, C 
CYP285 2 B, D 
CYP298 1 B 
The P450 family number ranged from nine to 30; S. clavuligerus and S. albus J1074 have the 
highest and lowest number of P450 families, respectively (Fig. 4.2A and Table 4.1). P450 subfamilies 
ranged from 15 to 58, with Streptomyces sp. 4F and S. clavuligerus having the lowest and highest 
number of P450 subfamilies (Fig. 4.2A and Table 4.1). Analysis of P450 families revealed that 25 
P450 families were highly populated and contributed 85% of all the P450s identified in 48 
Streptomyces species (Fig. 4.2B and Table 4.5). This indicates that these P450 families play an 
important role in Streptomyces species’ physiology and are thus maintained in high numbers. It is 
noteworthy that P450s possibly provide luxury functions, as most of the bacteria lack P450s. This 
phenomenon of maintaining the highest number of certain P450 family members is not new and has 
been observed in microorganisms such as fungi (Jawallapersand et al., 2014, Kgosiemang et al., 2014, 
Qhanya et al., 2015, Syed et al., 2014). However, unlike fungal species where only specific 
subfamilies are populated for a dominant P450 family (Jawallapersand et al., 2014, Kgosiemang et 
al., 2014, Qhanya et al., 2015, Syed et al., 2014), Streptomyces species’ dominant P450 family 
analysis revealed high diversity in terms of the number of subfamilies (Fig. 4.2C): the CYP107 family 
has 82 subfamilies, followed by CYP105 with 51 subfamilies, CYP183 with 23 subfamilies, CYP154 
with 14 subfamilies, CYP156 with eight subfamilies, CYP157 with seven subfamilies and CYP147 
with five subfamilies (Fig. 4.2C).  
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Table 4. 5. Comparative analysis of P450 family members in Streptomyces species. The percentage 
contribution of each P450 family is calculated as percentage contribution to the total number of P450s 
(1 625 P450s) identified in 48 Streptomyces species.  
P450 family Number of P450s % contribution to total number of P450s 
CYP107 381 23.4 
CYP105 225 13.8 
CYP157 123 7.6 
CYP154 119 7.3 
CYP156 56 3.4 
CYP147 52 3.2 
CYP183 48 3.0 
CYP102 45 2.8 
CYP159 37 2.3 
CYP125 33 2.0 
CYP158 31 1.9 
CYP163 28 1.7 
CYP180 27 1.7 
CYP113 22 1.4 
CYP170 21 1.3 
CYP1035 20 1.2 
CYP161 15 0.9 
CYP184 14 0.9 
CYP124 13 0.8 
CYP1047 11 0.7 
CYP152 11 0.7 
CYP1038 10 0.6 
CYP1199 10 0.6 
CYP155 10 0.6 
CYP285 10 0.6 
CYP1005 8 0.5 
CYP182 8 0.5 
CYP1060 7 0.4 
CYP251 7 0.4 
CYP1043 6 0.4 
CYP1064 6 0.4 
CYP1240 6 0.4 
CYP1046 5 0.3 
CYP108 5 0.3 
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CYP121 5 0.3 
CYP162 5 0.3 
CYP1029 4 0.2 
CYP1189 4 0.2 
CYP145 4 0.2 
CYP165 4 0.2 
CYP166 4 0.2 
CYP179 4 0.2 
CYP208 4 0.2 
CYP245 4 0.2 
CYP247 4 0.2 
CYP1031 3 0.2 
CYP1037 3 0.2 
CYP1278 3 0.2 
CYP134 3 0.2 
CYP1419 3 0.2 
CYP1423 3 0.2 
CYP171 3 0.2 
CYP178 3 0.2 
CYP1013 2 0.1 
CYP1036 2 0.1 
CYP1048 2 0.1 
CYP1061 2 0.1 
CYP1062 2 0.1 
CYP116 2 0.1 
CYP1190 2 0.1 
CYP1191 2 0.1 
CYP1192 2 0.1 
CYP1197 2 0.1 
CYP1198 2 0.1 
CYP1251 2 0.1 
CYP130 2 0.1 
CYP1341 2 0.1 
CYP135 2 0.1 
CYP136 2 0.1 
CYP140 2 0.1 
CYP1416 2 0.1 
CYP1417 2 0.1 
CYP1420 2 0.1 
CYP143 2 0.1 
CYP1453 2 0.1 
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CYP1530 2 0.1 
CYP1618 2 0.1 
CYP181 2 0.1 
CYP186 2 0.1 
CYP194 2 0.1 
CYP1995 2 0.1 
CYP199 2 0.1 
CYP2027 2 0.1 
CYP211 2 0.1 
CYP244 2 0.1 
CYP253 2 0.1 
CYP274 2 0.1 
CYP1039 1 0.1 
CYP1041 1 0.1 
CYP1042 1 0.1 
CYP1053 1 0.1 
CYP1054 1 0.1 
CYP1055 1 0.1 
CYP1056 1 0.1 
CYP1057 1 0.1 
CYP1058 1 0.1 
CYP1059 1 0.1 
CYP1063 1 0.1 
CYP1065 1 0.1 
CYP1066 1 0.1 
CYP1113 1 0.1 
CYP112 1 0.1 
CYP1151 1 0.1 
CYP1193 1 0.1 
CYP1194 1 0.1 
CYP1196 1 0.1 
CYP1207 1 0.1 
CYP1215 1 0.1 
CYP1222 1 0.1 
CYP1223 1 0.1 
CYP122 1 0.1 
CYP123 1 0.1 
CYP1248 1 0.1 
CYP1274 1 0.1 
CYP1339 1 0.1 
CYP1373 1 0.1 
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CYP1385 1 0.1 
CYP1392 1 0.1 
CYP1418 1 0.1 
CYP1422 1 0.1 
CYP1424 1 0.1 
CYP1457 1 0.1 
CYP1459 1 0.1 
CYP1469 1 0.1 
CYP146 1 0.1 
CYP1509 1 0.1 
CYP151 1 0.1 
CYP1694 1 0.1 
CYP1722 1 0.1 
CYP177 1 0.1 
CYP1813 1 0.1 
CYP2045 1 0.1 
CYP206 1 0.1 
CYP2108 1 0.1 
CYP2189 1 0.1 
CYP2238 1 0.1 
CYP2266 1 0.1 
CYP228 1 0.1 
CYP2340 1 0.1 
CYP246 1 0.1 
CYP268 1 0.1 
CYP282 1 0.1 
CYP283 1 0.1 
CYP298 1 0.1 
Comparative analysis of P450 family dynamics between the genera Streptomyces and 
Mycobacterium revealed the presence of the highest number of P450 families and P450 subfamilies 
in Streptomyces species (Fig. 4.4). Streptomyces species have 144 P450 families and 377 P450 
subfamilies compared to 77 P450 families and 132 P450 subfamilies identified in mycobacterial 
species (Fig. 4.4). Streptomyces species also have the highest number of new P450 families (66) and 
new P450 subfamilies (144) in their genomes compared to mycobacterial species (Fig. 4.4). 
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Interestingly, only two P450 families (CYP107 and CYP157) conserved in Streptomyces compared 
to mycobacterial species where 10 P450 families, namely CYP51, CYP123, CYP125, CYP130, 
CYP135, CYP136, CYP138, CYP140, CYP144 and CYP1128, were conserved (Parvez et al., 2016). 
Figure 4. 4. Comparative analysis of key features of P450s between the genera Streptomyces and 
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4.3 Streptomyces and Mycobacterium species show contrasting P450 profiles 
Comparative analysis of P450 profiles between the genera Streptomyces and Mycobacterium revealed 
that species belonging to these genera have different P450 profiles with few similarities (Fig. 4.5). 
Despite both genera belonging to the same phylum, Actinobacteria, only 21 P450 families were found 
to be common and quite a large number of P450 families were found to be unique to Streptomyces 
(123 P450 families) and Mycobacterium (56 P450 families) (Fig. 4.5). In the 21 P450 families 
commonly found between the two genera, an interesting feature was observed in terms of the number 
of member P450s (Fig. 4.6). A significant difference in the number of member P450s in the commonly 
shared P450 families was observed between Streptomyces and Mycobacterium (Fig. 4.6). The P450 
families CYP102, CYP105, CYP107, CYP147, CYP161 and CYP183 were highly populated in 
Streptomyces species, whereas the P450 families CYP108, CYP121, CYP123-CYP125, CYP130, 
CYP135, CYP136, CYP140, CYP143 and CYP268 were highly populated in mycobacterial species 
(Fig. 4.6). 
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Figure 4. 5. Comparative analysis of P450 families between Streptomyces and Mycobacterium. The 
numbers in parenthesis indicate the number of P450 families that are common and those that are 
unique to each genus. 
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Figure 4. 6. Comparative analysis of member P450s in P450 families common between the genera 
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Differences were also observed in the number of dominant P450 families in the two genera 
(Fig. 4.7A and B). Only seven P450 families, namely CYP107, CYP105, CYP157, CYP154, CYP156, 
CYP147 and CYP183, contributed 62% of all P450s in Streptomyces species, whereas 15 P450 
families, namely CYP125, CYP189, CYP150, CYP136, CYP135, CYP138, CYP140, CYP123, 
CYP143, CYP142, CYP144, CYP124, CYP108, CYP51 and CYP187, contributed 60% of all P450s 
in Mycobacterium (Fig. 4.7A and B). An interesting feature was that the percentage contribution of 
families was highest in Streptomyces, i.e. 23.4% by CYP107 and 13.8% by CYP105, compared to 
Mycobacterium P450 families, where the highest contribution was 6.4% by CYP125 (Fig. 4.7A and 
B). Furthermore, differences in P450 profiles between the two genera were observed in terms of type 
of dominant P450 families (Fig. 4.7A and B). A comparison of the dominant P450 families between 
the two genera revealed that none of the dominant P450 families was common between them (Figures 
4.5 and 4.7 A and B).    
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Figure 4. 7. Comparative analysis of dominant P450 families between the genera Streptomyces (A) 
and Mycobacterium (B). P450 families that are dominant in a genus are presented along with their 
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names and percentage contribution to the total number of P450s in a genus. A detailed analysis of the 
percentage contribution of each P450 family in Streptomyces species is presented in Table 4.5. 
4.4 Predicted functions of Streptomyces P450s 
Functional analysis of P450s based on characterised homolog P450s from other microorganisms and 
P450s from Streptomyces species (Rudolf et al., 2017) revealed that most of the Streptomyces P450s 
were involved in secondary metabolite production (Table 4.6). This strongly supports the concept that 
these Streptomyces P450s play a key role in the production of chemically diverse secondary 
metabolites, as a large number of P450 families were found in 48 Streptomyces species. Detailed 
analysis of P450 functions according to general functions and specific functions at P450 family and 
P450 subfamily level is presented in Tables 4.6 and Tables 4.7, respectively. The P450 family 
CYP180 was found to be part of a gene cluster that produces geosmin (Lamb et al., 2003). Among 
the P450 families involved in secondary metabolite production, 88 P450 families are uniquely present 
in Streptomyces species compared to mycobacterial species (Fig. 4.5 and Tables 4.6 and 47). P450 
families, namely CYP105, CYP107, CYP161, and CYP183, which are highly populated in 
Streptomyces species compared to mycobacterial species (Fig. 4.7), were found to be involved in 
secondary metabolite production (Tables 4.6 and 4.7). This strongly suggests that these P450 families 
have been populated in Streptomyces species owing to their importance and necessity in secondary 
metabolite production. Therefore, the diversity among these P450 families, judged by the large 
number of P450 subfamilies, presumably serves to increase the resultant chemical diversity further 
across different Streptomyces species. It is well established that P450s are one of the key enzymes 
contributing to the diversity of secondary metabolites in organisms (Greule et al., 2018). In contrast 
to the P450 families highly populated in Streptomyces species, P450 families that are highly populated 
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in mycobacterial species such as CYP125, CYP124, CYP108, CYP140 and CYP268 (Fig. 4.7B) are 
involved in steroid (cholesterol) and hydrocarbon (lipids, alkenes, long chain acetate and ketone) 
hydroxylation (Fig. 4.7B and Table 4.6), suggesting that these P450 families possibly help 
mycobacterial species to assimilate the host compounds. It is noteworthy that results from this study 
revealed that some of these P450 families are rarely (CYP125 and CYP140) or never (CYP268) part 
of secondary metabolite BGCs in mycobacterial species (Tables 4.6 and 4.7).  
Table 4. 6. Functional analysis of P450s. Functional analysis of P450s in Table 4.6 is presented at 
family level. Functional analysis of specific family members of the Streptomyces species is presented 
in Table 4.7. 
P450 family General function References 
Functional analysis of Streptomyces P450s 
CYP102 Fatty acid hydroxylation (Lamb et al., 2010) 
CYP105 Biotransformation or degradation of 
xenobiotics, and biosynthesis of secondary 
metabolites 
(Li et al., 2013, Moody and 
Loveridge, 2014) 
CYP107 Biosynthesis of secondary metabolites (Sherman et al., 2006) 
CYP113 Biosynthesis of secondary metabolites (Zhang et al., 2013) 
CYP122 Metabolism of terpenoids and polyketides (Chen et al., 2012) 
CYP158 Biosynthesis of secondary metabolites 
(flaviolin] 
(Zhao et al., 2012a, Zhao et al., 
2007) 
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CYP154 Production of secondary metabolites and 
hydroxylation of steroids 
(Cheng et al., 2010, Podust et 
al., 2004, Podust et al., 2003) 
CYP170 Biosynthesis of secondary metabolites (Moody et al., 2012, Takamatsu 
et al., 2011, Zhao et al., 2009) 
CYP1048 & 
CYP264 
Production of phytotoxins (Healy et al., 2000, Yu et al., 
2013) 
CYP161 Biosynthesis of secondary metabolites (Kelly et al., 2010) 
CYP151 & 
CYP248 
Biosynthesis of secondary metabolites (Zocher et al., 2011) 
CYP163 Biosynthesis of secondary metabolites (Haslinger et al., 2014) 
CYP129 & 
CYP131 
Biosynthesis of secondary metabolites (Dickens et al., 1997, Jaffrezou 
et al., 1996, Walczak et al., 
1999) 
CYP162 Biosynthesis of secondary metabolites (Xie et al., 2007) 
CYP245 & 
CYP244 
Biosynthesis of secondary metabolites (Huang, 2003, Molnár et al., 
1996) 
CYP183 Biosynthesis of secondary metabolites (Quaderer et al., 2006) 
Functional analysis of P450s from other microorganisms 
CYP121 Synthesis of mycocyclosin, a natural product (Belin et al., 2009) 
CYP125 Cholesterol oxidation (McLean et al., 2009, Ouellet et 
al., 2010) 
CYP124 Cholesterol and lipids hydroxylation (Johnston et al., 2009) 
CYP152 Alkene production (Belcher et al., 2014) 
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CYP108 Terpineol hydroxylation (Hasemann et al., 1994) 
CYP116 Degradation of toxic compounds (herbicides 
and alkyl aryl ethers) 
(Çelik et al., 2006, Warman et 
al., 2012) 
CYP140 Mycolactone toxin synthesis (Mve-Obiang et al., 2005) 
CYP165& 
CYP146 
Secondary metabolite production 
(vancomycin biosynthesis) 
(Cryle et al., 2010, Pylypenko et 
al., 2003) 
CYP199 Oxidation of benzoic acid derivatives (Bell et al., 2008, Bell et al., 
2012) 
CYP268 Hydroxylation of long chain branched 
acetate and ketone 
(Child et al., 2018) 
Table 4. 7. Functional analysis of P450s. Functional analysis of P450s was presented at P450 
subfamily level with respect to Streptomyces species.  
Species name CYP P450 Function References 
Streptomyces 
coelicolor A3(2) 
CYP170A1 Catalyses the oxidation of epi-
isozizaene to an epimeric mix of 
5-albaflavenol
(Zhao et al., 2009) 
CYP102B1 Fatty acid hydroxylase (Lamb et al., 
2010) 
CYP105N1 Oxidase in coelibactin siderophore 
biosynthesis 
Monooxygenase involved in 
coelibactin synthesis 
(Lim et al., 2012, 
Zhao et al., 2012a) 
CYP107U1 Putative steroid oxidase with role 
in sporulation and antibiotic 
synthesis 
(Tian et al., 2013) 
CYP154A1 Di-pentaenone cyclisation 
Involved in polyketide metabolism 
(Podust et al., 
2004, Cheng et al., 
2010) 




C–C coupling in flaviolin 
polymerisation 
(Zhao et al., 2007, 
Zhao et al., 
2012b) 
CYP170A1 Two-step allylic oxidation of epi-
isozizaene to albaflavenone in 
albaflavenone biosynthesis 
(Zhao et al., 2009) 
CYP154C1 12- and 14-carbon macrolactone
monooxygenase
e.g., narbomycin hydroxylase









Fatty acid hydroxylase (Choi et al., 2012, 
Xu et al., 2010) 
CYP107W1 Oligomycin (Han et al., 2015) 
CYP105D6 C1-hydroxylation of filipin (Xu et al., 2010) 
CYP105D7 Filipin hydroxylase 
1-deoxypentalenic acid
hydroxylase
(Takamatsu et al., 
2011) 
CYP105P1 Filipin hydroxylation (Xu et al., 2010) 
CYP170A2 Two-step allylic oxidation of epi-
isozizaene to albaflavenone 
(Takamatsu et al., 
2011) 
CYP171A1 C6 and C8a avermectin algycone 
hydroxylation 
(Lamb et al., 
2011) 
CYP183A Pentalene hydroxylase  (Quaderer et al., 
2006) 
Streptomyces scabiei CYP1048A1 Direct nitration of L-tryptophan 
with NO, O2, redox partners, and 
NADPH 
Plays a novel catalytic role in the 
biosynthesis of a cyclic dipeptide 
phytotoxin 
Involved in the production of the 
plant toxin thaxtomin, responsible 
for potato common scab 
(Challis et al., 
2012, Lawrence et 
al., 1990, Yu et 
al., 2013) 
CYP246A1 Thaxtomin phenylalanyl di-
hydroxylase in thaxtomin A 
biosynthesis 
(Healy et al., 
2002) 




CYP105A1 Catalyses highly selective 
oxidations of diterpenoids 
Vitamin D3 hydroxylase involved 
in the conversion of vitamin D3 to 
its active form 1α,25-hydroxy 
vitamin D3 
(Hayashi et al., 
2008, Janocha et 
al., 2013, 
Sugimoto, 2008) 
CYP154C3 Catalyses monooxygenation 
reactions of a range of steroids 




CYP107L1 Involved in ring decoration of 
macrolide antibiotics 
Catalyses regioselective C-12 
hydroxylation of narbomycin (the 
final step of pikromycin 
biosynthesis) 
12- and 14- carbon macrolactone,
e.g narbomycin and YC-17
hydroxylation







in pimaricin biosynthesis 






Oxidation and ring formation to 
convert deoxyaureothin to 
aureothin 
(Zocher et al., 
2011) 







ʸ-Hydroxylation of an unusual 
pipera-zic acid (Pip) motif in 
himastatin biosynthesis 





HmtT Regio- and stereospecific C2/C3 
epoxidation of L-tryptophan 










Three successive β-hydroxylations 
of separate PCP-bound L-amino 
acid precursors in skyllamycin 
biosynthesis 
(Haslinger et al., 








Polyketide oxidative tailoring 
reactions 
(Agarwal, 2006, 
Caffrey et al., 
2001) 




CYP107C1 C12-C13 epoxidation of 
carbomycin B to make 
carbomycin C 
(Ashy et al., 1980) 
Streptomyces 
bikiniensis 
ChmH1 C20 methyl macrolide 
hydroxylation 
















C10,C13, C14 anthracycline 
glycine DNR precursor 
hydroxylations and likely 
aglycone core oxidation 
(Dickens et al., 
1997, Jaffrezou et 
al., 1996, Walczak 
et al., 1999) 
Streptomyces 
graminofaciens 
GfsF C8-9 macrolide epoxidation then 
C10 hydroxylation 
(Kataoka et al., 






Four-electron C-9 FK506 
precursor oxidation 
(Chen et al., 2012) 
Streptomyces 
pulveraceus 
FosK C18 fostriecin hydroxylation (Kong et al., 2013, 







Piperazic acid (Pip) motif ʸ-
hydroxylation and C2/C3L-
tryptophan epoxidation cyclisation 
to hexahydropyrroloindole and 
biaryl aromatic coupling of 
depsipeptide monomers 
(LEET et al., 
1996, Ma et al., 
2011, Zheng et al., 
2013) 
Streptomyces tendae CYP162A1 Histidine β-hydroxyation to form 
nikkomycins X and I 
(Lauer et al., 








(Chen and Walsh, 
2001, Steffensky 
et al., 2000) 
Streptomyces 
peucetius 
CYP105F2 Oleandomycin tailoring 
hydroxylation 
(Rodriguez et al., 
1995, Shrestha et 
al., 2008) 
CYP107A1 Catalyses the H2O2-mediated 
dealkylation of 7-ethoxycoumarin 
(Niraula et al., 
2011) 









C9, C26, C27 and C32 rapamycin 
macrolactone hydroxylation  
(Huang, 2003, 








Aryl-aryl coupling of 
chromopyrrolic acid and C-N 
linkage of staurosporine aglycone  
(Huang, 2003, 




TauI/TmcR C5 tautomycetin oxygenation D. Kim et al.,









Likely C23 methyl lactone ring 
oxidase (CYP105L1) and C20 
methyl O-mycaminosyl-tylactone 
hydroxylation (CYP113B1) 






TamI C10 oxidation of tirandamycin C 
to E, then C11-12 epoxidation C18 
hydroxylation  
(Carlson et al., 
2010, Carlson et 
al., 2011) 
Streptomyces albus CYP170B1 Produces albaflavenone from epi-
isozizaene 
(Moody et al., 
2012) 
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CHAPTER 5 
CONCLUSION AND FUTURE PERSPECTIVES 
Adaptation is key for the survival of an organism. Organisms adapt to different ecological niches by 
changing their gene pool and thus changing their physiology to make them suitable for survival in the 
new environment. The effect of ecological niches or lifestyle on P450s’ evolution in organisms such 
as animals, plants, fungi and oomycetes has been observed. In this study, for the first time, the 
influence of lifestyle on the evolution of P450s in a bacterial population has been presented. Ample 
evidence of the impact of lifestyle on shaping the P450 profile in species belonging to the genera 
Streptomyces and Mycobacterium is identified in the study. It is clear that different lifestyles 
influenced the P450 profiles in Streptomyces and Mycobacterium, hence the differences observed 
between the two genera in terms of number of P450s, P450 family and subfamily diversity, type of 
dominant and unique P450 families and differences in number of P450s in common P450 families. 
Furthermore, functional analysis of P450s suggests that in Streptomyces, P450s are destined for 
secondary metabolite production, whereas in Mycobacterium they are destined for utilisation of host 
lipids or synthesis of novel lipids. Future works involves assessing the physiological function of P450s 
in order to identify their role, if any, in the adaptation of Streptomyces species or mycobacterial 
species to different ecological niches. 
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